ProAssurance (NYSE:PRA) Earns Hold Rating from Analysts at StockNews.com
by Scott Moore · The Cerbat GemStockNews.com assumed coverage on shares of ProAssurance (NYSE:PRA – Free Report) in a report released on Saturday. The brokerage issued a hold rating on the insurance provider’s stock.
PRA has been the topic of several other reports. Citigroup downgraded ProAssurance to a “market perform” rating in a research note on Thursday, April 3rd. Citizens Jmp lowered ProAssurance from an “outperform” rating to a “market perform” rating in a research note on Thursday, April 3rd. Finally, Raymond James lowered shares of ProAssurance from a “market perform” rating to an “underperform” rating in a research report on Thursday, April 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, ProAssurance presently has an average rating of “Hold” and a consensus price target of $18.67.
Check Out Our Latest Research Report on ProAssurance
ProAssurance Stock Performance
PRA stock opened at $22.99 on Friday. ProAssurance has a one year low of $10.76 and a one year high of $23.70. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 27.70 and a beta of 0.04. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a 50-day simple moving average of $20.88 and a two-hundred day simple moving average of $17.47.
ProAssurance (NYSE:PRA – Get Free Report) last posted its earnings results on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.19. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The company had revenue of $287.52 million during the quarter, compared to analysts’ expectations of $274.56 million. On average, equities analysts forecast that ProAssurance will post 0.8 EPS for the current fiscal year.
Institutional Trading of ProAssurance
Several large investors have recently added to or reduced their stakes in PRA. Sterling Capital Management LLC raised its stake in shares of ProAssurance by 859.4% in the fourth quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider’s stock worth $26,000 after purchasing an additional 1,461 shares during the last quarter. GAMMA Investing LLC raised its position in ProAssurance by 307.3% during the 1st quarter. GAMMA Investing LLC now owns 2,073 shares of the insurance provider’s stock worth $48,000 after buying an additional 1,564 shares during the last quarter. CWM LLC lifted its stake in ProAssurance by 95.9% during the 1st quarter. CWM LLC now owns 2,204 shares of the insurance provider’s stock valued at $51,000 after acquiring an additional 1,079 shares during the period. KBC Group NV boosted its holdings in shares of ProAssurance by 75.4% in the 4th quarter. KBC Group NV now owns 4,184 shares of the insurance provider’s stock valued at $67,000 after acquiring an additional 1,798 shares during the last quarter. Finally, Aquatic Capital Management LLC increased its stake in shares of ProAssurance by 148.6% in the fourth quarter. Aquatic Capital Management LLC now owns 6,214 shares of the insurance provider’s stock worth $99,000 after acquiring an additional 3,714 shares during the period. Hedge funds and other institutional investors own 85.58% of the company’s stock.
About ProAssurance
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
See Also
- Five stocks we like better than ProAssurance
- The Most Important Warren Buffett Stock for Investors: His Own
- Monster Beverage Stock: Short Report Risks vs Upside Potential
- Quiet Period Expirations Explained
- Onsemi Stock Confirms Bottom, But What’s the Upside?
- Differences Between Momentum Investing and Long Term Investing
- 3 Tech Leaders Announce Buybacks Totaling $85 Billion